Loading...

ORKA ORUKA THERAPEUTICS INC Management Changes 8-K Filing

RK T

RK

ORUKA THERAPEUTICS INC

(ORKA)

2025 8-K

Offering Update

Clinical Trial Results

Management Changes

Private Placement Details

License Agreement

License Agreement

Stockholder Meeting

Merger Completion

Management Changes

Private Placement

Merger Completion

Merger Announcement

Asset Purchase Agreement

Financial Results

Amendment Agreement

Financial Results

Retention Bonus Amendment

Departure of CEO and Appoin...

Merger Agreement

Lease Amendment

Resignations from Board of ...

Financial Results

Compensation and Annual Mee...

Retention Bonus Amendment

Financial Results

Earnings Releases

Financial Results

External Links:

On July 1, 2025, Oruka Therapeutics, Inc. appointed Laura Sandler as the Chief Operating Officer, with an annual salary of $460,000 and eligibility for a 40% bonus. Sandler also received a stock option for 25,000 shares, vesting over four years, including severance benefits.

AI Assistant

ORUKA THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.